PTC Therapeutics, Inc. (PTCT)

69.89 -0.77 (-1.09%) USD  |  NASDAQ  |  Feb 23, 13:52
More

PTC Therapeutics Long Term Deferred Assets (Quarterly)

Long Term Deferred Assets (Quarterly) Chart

View Long Term Deferred Assets (Quarterly) for PTCT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Long Term Deferred Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Long Term Deferred Assets (Quarterly) Range, Past 5 Years

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Long Term Deferred Assets (Quarterly) Benchmarks

View Long Term Deferred Assets (Quarterly) Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. Upgrade
Sarepta Therapeutics, Inc. --
Ardelyx, Inc. --
Spyre Therapeutics, Inc. --
Ovid Therapeutics, Inc. --